NS
AUTL icon

NBC Securities’s Autolus Therapeutics AUTL Stock Holding History

NBC Securities’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-800
Closed -$2K – 1306
2024
Q3 		$2K Hold
800
– – ﹤0.01% 2000
2024
Q2 		$2K Hold
800
– – ﹤0.01% 1966
2024
Q1 		$5K Hold
800
– – ﹤0.01% 1844
2023
Q4 		$5K Hold
800
– – ﹤0.01% 1856
2023
Q3 		$1K Buy
+800
New +$2.28K ﹤0.01% 2052

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

NBC Securities's AUTL Position: Q4 2024 in Review

NBC Securities sold out of Autolus Therapeutics (AUTL) in Q4 2024, closing a stake of 800 shares — an estimated $2K sold.

NBC Securities first reported a position in AUTL in Q3 2023 and held it in 5 quarters. The position peaked at $5K in Q1 2024. 110 funds tracked by Wall St. Rank hold AUTL as of Q4 2024.

  • NBC Securities reported no remaining Autolus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NBC Securities sold 800 Autolus Therapeutics shares in Q4 2024, an estimated $2K.
  • NBC Securities first reported a position in Autolus Therapeutics in Q3 2023 and held it in 5 quarters.
  • NBC Securities's Autolus Therapeutics position peaked at $5K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2024.

Based on NBC Securities's 13F filing for Q4 2024, filed 22 Jan 2025.